These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12079871)

  • 21. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.
    Shi Y; Hon M; Evans RM
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2613-8. PubMed ID: 11867749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes.
    Marcus SL; Miyata KS; Rachubinski RA; Capone JP
    Gene Expr; 1995; 4(4-5):227-39. PubMed ID: 7787415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional relationship between MyoD and peroxisome proliferator-activated receptor-dependent regulatory pathways in the control of the human uncoupling protein-3 gene transcription.
    Solanes G; Pedraza N; Iglesias R; Giralt M; Villarroya F
    Mol Endocrinol; 2003 Oct; 17(10):1944-58. PubMed ID: 12843208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription.
    Schroeder F; Petrescu AD; Huang H; Atshaves BP; McIntosh AL; Martin GG; Hostetler HA; Vespa A; Landrock D; Landrock KK; Payne HR; Kier AB
    Lipids; 2008 Jan; 43(1):1-17. PubMed ID: 17882463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
    Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
    Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisomal bifunctional enzyme binds and activates the activation function-1 region of the peroxisome proliferator-activated receptor alpha.
    Juge-Aubry CE; Kuenzli S; Sanchez JC; Hochstrasser D; Meier CA
    Biochem J; 2001 Jan; 353(Pt 2):253-8. PubMed ID: 11139388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver.
    Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H
    Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.
    Leesnitzer LM; Parks DJ; Bledsoe RK; Cobb JE; Collins JL; Consler TG; Davis RG; Hull-Ryde EA; Lenhard JM; Patel L; Plunket KD; Shenk JL; Stimmel JB; Therapontos C; Willson TM; Blanchard SG
    Biochemistry; 2002 May; 41(21):6640-50. PubMed ID: 12022867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
    Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
    Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPARs: transcriptional effectors of fatty acids and their derivatives.
    Hihi AK; Michalik L; Wahli W
    Cell Mol Life Sci; 2002 May; 59(5):790-8. PubMed ID: 12088279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure.
    Portilla D; Dai G; McClure T; Bates L; Kurten R; Megyesi J; Price P; Li S
    Kidney Int; 2002 Oct; 62(4):1208-18. PubMed ID: 12234291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptors (PPAR) and the mitochondrial aldehyde dehydrogenase (ALDH2) promoter in vitro and in vivo.
    Crabb DW; Pinaire J; Chou WY; Sissom S; Peters JM; Harris RA; Stewart M
    Alcohol Clin Exp Res; 2001 Jul; 25(7):945-52. PubMed ID: 11505017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response.
    Feingold K; Kim MS; Shigenaga J; Moser A; Grunfeld C
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E201-7. PubMed ID: 14701665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different Coactivator Recruitment to Human PPARα/δ/γ Ligand-Binding Domains by Eight PPAR Agonists to Treat Nonalcoholic Fatty Liver Disease.
    Kamata S; Honda A; Kashiwagi N; Shimamura A; Yashiro S; Komori Y; Hosoda A; Akahoshi N; Ishii I
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors.
    Xu HE; Lambert MH; Montana VG; Parks DJ; Blanchard SG; Brown PJ; Sternbach DD; Lehmann JM; Wisely GB; Willson TM; Kliewer SA; Milburn MV
    Mol Cell; 1999 Mar; 3(3):397-403. PubMed ID: 10198642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.
    Lim HJ; Moon I; Han K
    Endocrinology; 2004 Jun; 145(6):2886-95. PubMed ID: 15001550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
    Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
    Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.
    Leone TC; Weinheimer CJ; Kelly DP
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7473-8. PubMed ID: 10377439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
    Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE
    Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.